Literature DB >> 31092380

EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists.

Marie-Madeleine Dolmans1, Matteo Lambertini2, Kirsten Tryde Macklon3, Teresa Almeida Santos4, Ana Ruiz-Casado5, Andrea Borini6, Virginie Bordes7, Lucy Frith8, Ellen Van Moer9, Ariane Germeyer10.   

Abstract

In recent years, following the improved prognosis of patients with cancer, interest and attention has grown around fertility issues in these patients. International guidelines on fertility preservation in patients with cancer recommend that physicians discuss with all patients of reproductive age (or their parents/guardians, if children) the risk of infertility arising from their cancer or its treatment. Oncofertility counselling is recommended at the earliest opportunity and prior to cancer treatment, to help patients make informed decisions on pursuing fertility preservation. Currently, however, such discussions are not being routinely held. In June 2017, an esteemed group of European oncofertility experts met to discuss current unfulfilled needs in oncofertility for female cancer patients. This expert group has produced here a number of key recommendations in order to guide oncologists, haematologists, and other involved professionals with oncofertility discussions and appropriate referrals for further fertility preservation counselling and follow-up.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Expert recommendations; Female cancer patients; Fertility preservation; Haematologists; Oncofertility; Oncologists

Mesh:

Substances:

Year:  2019        PMID: 31092380     DOI: 10.1016/j.critrevonc.2019.03.010

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  11 in total

1.  Disparities in fertility preservation use among adolescent and young adult women with cancer.

Authors:  Clare Meernik; Stephanie M Engel; Ally Wardell; Christopher D Baggett; Parul Gupta; Nidia Rodriguez-Ormaza; Barbara Luke; Valerie L Baker; Ethan Wantman; Jose Alejandro Rauh-Hain; Jennifer E Mersereau; Andrew F Olshan; Andrew B Smitherman; Jianwen Cai; Hazel B Nichols
Journal:  J Cancer Surviv       Date:  2022-02-16       Impact factor: 4.062

2.  Impact of COVID-19 Pandemic on Gynecological Oncology Care: Glimpse into Association of Gynecological Oncologists of India (AGOI) Perspective.

Authors:  Geetu Bhandoria; T S Shylasree; Prashant Bhandarkar; Vijay Ahuja; Amita Maheshwari; Rupinder Sekhon; S P Somashekhar
Journal:  Indian J Gynecol Oncol       Date:  2020-06-15

Review 3.  Fertility after Cancer: Risks and Successes.

Authors:  Chiara Di Tucci; Giulia Galati; Giulia Mattei; Alessandra Chinè; Alice Fracassi; Ludovico Muzii
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

4.  Adipose tissue-derived stem cells protect the primordial follicle pool from both direct follicle death and abnormal activation after ovarian tissue transplantation.

Authors:  Luciana Cacciottola; Guillaume E Courtoy; Thu Y T Nguyen; Camille Hossay; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  J Assist Reprod Genet       Date:  2020-11-12       Impact factor: 3.412

5.  Counseling young women with early breast cancer on fertility preservation.

Authors:  M E Elena Ter Welle-Butalid; I J H Ingeborg Vriens; J G Josien Derhaag; E M Edward Leter; C E Christine de Die-Smulders; M Marjolein Smidt; R J T Ron van Golde; V C G Vivianne Tjan-Heijnen
Journal:  J Assist Reprod Genet       Date:  2019-11-23       Impact factor: 3.412

Review 6.  Chemotherapy Associated Ovarian Failure.

Authors:  Davide Mauri; Ioanna Gazouli; Georgios Zarkavelis; Alexandra Papadaki; Leonidas Mavroeidis; Stefania Gkoura; Panagiotis Ntellas; Anna-Lea Amylidi; Lampriani Tsali; Eleftherios Kampletsas
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-08       Impact factor: 5.555

Review 7.  GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation.

Authors:  Georgios Valsamakis; Konstantinos Valtetsiotis; Evangelia Charmandari; Irene Lambrinoudaki; Nikolaos F Vlahos
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

8.  Protective effects of a SIRT1 inhibitor on primordial follicle activation and growth induced by cyclophosphamide: insights from a bovine in vitro folliculogenesis system.

Authors:  Giovanna Di Emidio; Carla Tatone; Vincenza Barbato; Vincenzo Genovese; Martina Placidi; Riccardo Talevi; Roberto Gualtieri
Journal:  J Assist Reprod Genet       Date:  2022-03-05       Impact factor: 3.357

9.  Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.

Authors:  Charlotte Sonigo; Nelly Frydman; Anne Mayeur; Vincent Puy; Victoria Windal; Laetitia Hesters; Vanessa Gallot; Alexandra Benoit; Michael Grynberg
Journal:  J Assist Reprod Genet       Date:  2021-04-01       Impact factor: 3.357

10.  Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients.

Authors:  Tristan Zver; Sophie Frontczak; Catherine Poirot; Aurélie Rives-Feraille; Brigitte Leroy-Martin; Isabelle Koscinski; Francine Arbez-Gindre; Francine Garnache-Ottou; Christophe Roux; Clotilde Amiot
Journal:  J Ovarian Res       Date:  2022-01-18       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.